10 spots left to join us for the Digiday Publishing Summit

Join us Sept. 14-16 in Miami to connect with top publishing leaders

SECURE YOUR SEAT

Mushroom boardroom: Why some execs are using psychedelics to get through the workday

work overload gif

This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.

After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.

Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.

More in Marketing

OpenAI builds offerings on consent as it expands ChatGPT ads to Europe

The company’s new EU privacy policy goes live “later this month”.

ANA updates efforts to standardize retail media network measurement

The ANA is hammering out guidelines around standardization of retail media measurement, on behalf of its member base of marketers

How DTC startups are using AI to scale more efficiently

Brand marketers are recreating the DTC playbook for the current agentic AI landscape.